Navigation Links
Saint Louis U scientists partner on malaria research
Date:2/18/2011

ST. LOUIS -- The Center for World Health & Medicine at Saint Louis University and China's Guangzhou Institutes of Biomedicine and Health (GIBH) are forming a global research partnership that initially will focus on new treatments for malaria.

The organizations are not only connected by a shared commitment to fight a devastating disease, but their key leaders are former Pfizer Inc. drug discovery scientists who formerly worked together in Chesterfield, Mo.

GIBH is part of the Chinese Academy of Sciences, a premier government scientific research organization in China, which is similar to the U.S. National Science Foundation. Its chief technology officer and vice president of research, Micky Tortorella, has held the position for more than a year after leaving Pfizer.

The Center for World Health & Medicine began with a dozen scientists at Saint Louis University in July, with a goal of turning basic science research into drugs that combat diseases and medical problems that largely afflict the developing world.

"This is the first step in setting up an international network of collaboration fueled by scientists with expertise in drug discovery. This alliance gives us a global expertise, and provides a real opportunity to succeed, in terms of developing safe, effective and affordable new drugs," said Peter Ruminski, executive director of the Center for World Health & Medicine.

"Malaria is becoming increasingly resistant to current treatments. We need new classes of drugs to attack this deadly disease, which kills between one and three million people a year. We think it is important for there to be multiple therapeutic options for treating malaria, as there are for HIV or for bacterial infections, and this partnership will add significantly to efforts aimed at achieving that goal."

Tortorella said there is a real need for novel approaches to treat malaria, which is a devastating problem in China and in other parts of the developing world, including Africa.

"Every year there are between 300 and 500 million cases of malaria, primarily in the developing world, making it a global priority that currently is not being met. This is an international partnership between China and the United States, working on an international goal. Biologists and medicinal chemists from both of our organizations will work together," Tortorella said.

Considered a disease of poverty, malaria is spread by mosquitoes in tropical and subtropical regions.

"Diseases of poverty that are prevalent in the developing world, have enormous health and socio-economic consequences," Ruminski said.

"What we're doing here trying to find safe, effective and affordable new drugs fits into the mission of Saint Louis University. We're helping those who are under-served. We want to make sure that everyone, regardless of whether they are rich or poor, has access to the newest drugs."

Tortorella looks forward to what could come from the collaboration with former colleagues.

"We started together and it's come full circle. We're now working together again, this time as part of an international partnership between China and the United States, working on an international goal. We're taking advantage of each other's expertise as we work together," Tortorella said. "I see us as pioneers."

Raymond Tait, Ph.D., vice president for research at Saint Louis University, echoed the pioneering sentiment.

"We have believed from the outset that the Center would forge innovative relationships as our scientists pursue new treatments for global diseases. I am delighted at the GIBH partnership and hope that it is the first of many such partnerships that the Center will form."


'/>"/>

Contact: Nancy Solomon
solomonn@slu.edu
314-977-8017
Saint Louis University
Source:Eurekalert

Related medicine news :

1. Welsh Tree LLC Proudly Presents the Release of the Celtic Pathways CD by Jason Evans, in Time for Saint Patrick's Day
2. The ‘Hugging Saint' Amma Visits Dallas June 27-28, 2010, Offering Spiritual Upliftment to People of All Faiths
3. Better cholesterol drugs may follow Saint Louis University researchers breakthrough
4. SHARECOR Partners With Quantros, Inc. to Facilitate Core Measures and Regulatory Reporting in Louisiana Hospitals
5. Pew Report: Louisiana Failing to Address Childrens Dental Health Crisis
6. Penn researcher, Louis J. Soslowsky, PhD, winner of the AAOS Kappa Delta Ann Doner Vaughan Award
7. New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Louisiana is 46th Among All States in Maternal Mortality
8. Louisiana Law Firm Neblett, Beard & Arsenault Launches New Foodborne Illness Site
9. The Net Impact Creates Website for St. Louis Event to Combat the Stigma of Mental Illness
10. Eight-Year-Old Creates Mini-Documentary on St. Louis Children's Hospital Life
11. Louisiana Tech students, faculty earn accolades from Louisiana Dietetic Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... , ... Harris Communications, Inc., a leading provider of assistive technology for ... Deaf Seniors of America Conference, April 4-7 at the Hotel Westin Galleria in Houston. ... staff from Harris Communications and to try out the newest assistive devices available to ...
(Date:3/25/2017)... ... , ... Getting earned media coverage meaningful for Garden Media Group's clients is ... year, Garden Media aims to provide material helpful to clients’ goals and bottom lines. ... key messages to gain coveted media placements, Garden Media wows clients year-round. , ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... solutions for contaminated soil, dredged material, and hazardous and non-hazardous materials announced today ... Allentown, Pennsylvania. This acquisition will add four additional processing facilities and a ...
(Date:3/24/2017)... ... March 24, 2017 , ... Mediaplanet today ... conversation on the current obstacles facing infection prevention and offer strategies for the ... by these infections. , The print component of “Fighting Infection” is distributed ...
(Date:3/24/2017)... ... March 24, 2017 , ... Digital Scientists, a software innovation lab specializing in ... a Greenville, South Carolina location. The lab has set up shop at ... been working with South Carolina clients for years from our office here in Atlanta,” ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... and BOSTON , March 27, ... global pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: ... and commercialization of innovative therapies based upon tetracycline ... of sarecycline for the treatment of moderate to ... endpoints. Sarecycline is a once-daily, oral, narrow spectrum ...
(Date:3/27/2017)... 27, 2017  PhaseRx, Inc. (NASDAQ: PZRX), a ... liver diseases in children, today reported financial results ... December 31, 2016 and provided an update on ... to make progress during the fourth quarter of ... our non-human primate safety study, and with our lead ...
(Date:3/24/2017)... , Mar 24, 2017 Research ... Therapy Manufacturing Market, 2017-2027" report to their offering. ... The Cell ... the rapidly growing market of cell therapy manufacturing and focuses ... manufacturing facilities. These therapies are anticipated to emerge as viable ...
Breaking Medicine Technology: